We’re exploring some of the most common triggers of seizure clusters and practical tips on how to avoid or manage these risks ...

Q3 2024 Earnings Call Transcript November 4, 2024 Supernus Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is ...

Net sales of Qelbree ® increased 68% in the third quarter of 2024, compared to the same period in 2023. Net sales of Qelbree of $62.4 million and $166.9 million in the third quarter and first nine ...

who completed a post-baseline seizure diary had at least one four-week seizure free period. Post-maintenance extension period: 1 out of 6 subjects (17%) had at least one four-week seizure free period.

A developmental cognitive neuroscientist at The University of Texas at Dallas’ Center for Vital Longevity is exploring an ...

Good afternoon, and welcome to Supernus Pharmaceuticals Third Quarter 2024 Financial Results Conference Call. At this time, all participants are in listen-only mode. Later, we will conduct a ...

Traditionally, clinical trials have had to rely upon patients to self-report in a diary when a seizure happens, a process known to be inaccurate. Over 40% of the most dangerous generalized tonic ...

His GP confirmed his medical history of epilepsy, osteoporosis, and respiratory failure. He kept a day-to-day diary which offered an insight into his life, including the final entry a couple of weeks ...